Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker

Overview

The management of acute diverticulitis maybe better if we have prognostic markers of evolution. Hypothesis: C-reactive protein maybe a good prognostic marker of evolution of acute diverticulitis. The investigators need to know the values of C-reactive protein to predict evolution of acute diverticulitis.

Full Title of Study: “Predictive Value of C-Reactive Protein in Acute Diverticulitis”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: April 2014

Detailed Description

A prospective observational study. All the patients with TC-diagnosis of acute diverticulitis (AD) had a C-reactive protein (PCR) in the initial blood test. The investigators will predict evolution of AD with the PCR initial.

Interventions

  • Other: C-reactive protein
    • measured C-reactive protein in all patients with acute diverticulitis

Arms, Groups and Cohorts

  • Acute Diverticulitis
    • We measured C-reactive protein in all the patients diagnosed with acute diverticulitis

Clinical Trial Outcome Measures

Primary Measures

  • C-Reactive Protein
    • Time Frame: 24 Hours

Participating in This Clinical Trial

Inclusion Criteria

  • Acute Diverticulitis Exclusion Criteria:

  • Other Abdominal Pathologies

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Corporacion Parc Tauli
  • Provider of Information About this Clinical Study
    • Principal Investigator: LAURA MORA LOPEZ, General Surgeon – Corporacion Parc Tauli
  • Overall Official(s)
    • MORA LAURA, MD, Principal Investigator, Corporacion Parc Tauli
  • Overall Contact(s)
    • MORA L. LAURA, MD, 34639101033, Lmora@tauli.cat

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.